Standard Pharmaceuticals Ltd, a active public limited company, was established on 04 December 1995 in Kolkata, West Bengal, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232WB1995PLC075698. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹13.50 Cr and a paid-up capital of ₹13.41 Cr.
It upholds a compliant status. Employing 59 professional, Its leadership includes Tarun Mall Kumar (Whole-Time Director), Bhabani Prasad Dey (Director), Omesh Kumar Sethi (Managing Director). Past directors included Ajay Mall, Rajendra Prasad Tewari, Tarun Mall Kumar. It holds ₹21.36 Cr open charges and ₹45.30 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 27 Mirza Galib Street, Kolkata, West Bengal, 700016.
U24232WB1995PLC075698
075698
04 December 1995
₹13.50 Cr
₹13.41 Cr
Roc Kolkata
Unlisted
Active
Explore comprehensive insights into Standard Pharmaceuticals Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Tarun Mall Kumar | Whole-Time Director | 18 Feb 2009 | Current |
| Bhabani Prasad Dey | Director | 25 May 2016 | Current |
| Omesh Kumar Sethi | Managing Director | 30 Sep 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 05 Feb 2014 | Past |
| Pramod Abcsdd | Director | 08 Nov 2010 | Past |
| Pramod Abcsdd | Director | 01 Apr 2013 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2015 | Past |
| Pramod Abcsdd | Director | 18 Nov 2008 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Standard Pharmaceuticals Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 88.86% increase. The company also saw a substantial fall in profitability, with a 36.53% decrease in profit. The company's net worth moved up by a moderate rise of 2.68%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Standard Pharmaceuticals had a promoter holding of 93.69% and a public holding of 6.31%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹213,622,000.00
₹452,962,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Apr 2018 | Others | ₹1.10 Cr | Open |
| 25 Aug 2017 | Others | ₹12.85 Cr | Open |
| 01 Nov 1999 | The Federal Bank Limited | ₹7.41 Cr | Open |
| 27 Jun 2018 | Tata Capital Financial Services Limited | ₹8.45 M | Satisfied |
| 26 Feb 2016 | Religare Finvest Limited | ₹2.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Standard Pharmaceuticals has a workforce of 59 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Standard Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Standard Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Standard Pharmaceuticals Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity A charge registered on 27 Jun 2018 via Charge ID 100188295 with Tata Capital Financial Services Limited was fully satisfied on 28 Aug 2024. was completed.
The activity Standard Pharmaceuticals Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kolkata. was completed.
The activity A charge with Tata Capital Financial Services Limited amounted to Rs. 0.85 Cr with Charge ID 100188295 was registered on 27 Jun 2018. was completed.
A charge with Others amounted to Rs. 1.10 Cr with Charge ID 100193235 was registered on 27 Apr 2018. was recorded as a recent event.
A charge with Others amounted to Rs. 12.85 Cr with Charge ID 100120462 was registered on 25 Aug 2017. was recorded as a recent event.
The CIN of Standard Pharmaceuticals Ltd is U24232WB1995PLC075698.
Standard Pharmaceuticals Ltd is headquartered at 27 Mirza Galib Street, Kolkata, West Bengal, 700016.
Standard Pharmaceuticals Ltd was incorporated on 04 December 1995.
The current directors of Standard Pharmaceuticals Ltd are
The primary industry of Standard Pharmaceuticals Ltd is Manufacturing.
Standard Pharmaceuticals Ltd is unlisted.
The authorized capital of Standard Pharmaceuticals Ltd is ₹13.50 Cr, and the paid-up capital is ₹13.41 Cr.
The compliance status of Standard Pharmaceuticals Ltd is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX